Relay Therapeutics News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected news for Relay Therapeutics, which is filed under Sectors / Healthtech. There are 1K news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
7/9/2022 Donald A. Bergstrom Sells 8,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock - WKRB News
Relay Therapeutics, Inc. ( NASDAQ:RLAY – Get Rating ) insider Donald A. Bergstrom sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, July 6th. The shares were sold at an average price of $20.00, for a total value of $160,000.00. Following the completion of the transaction, the ...
wkrb13.com
7/8/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $41.00 Consensus Target Price from Analysts - Stock Observer
Relay Therapeutics, Inc. ( NASDAQ:RLAY – Get Rating ) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and four have issued a buy rating on the ...
thestockobserver.com
7/6/2022 Brokerages Set Relay Therapeutics, Inc. (NASDAQ:RLAY) PT at $41.00
Relay Therapeutics, Inc. ( NASDAQ:RLAY – Get Rating ) has been given a consensus recommendation of “Moderate Buy” by the eight analysts that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the ...
baseballnewssource.com
7/6/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $41.00 Average PT from Analysts zolmax.com
7/6/2022 Brokerages Set Relay Therapeutics, Inc. (NASDAQ:RLAY) PT at $41.00 rivertonroll.com
7/4/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $41.00 Consensus PT from Brokerages - Ticker Report Ticker Report
7/3/2022 Relay Therapeutics (NASDAQ:RLAY) Trading Up 4.7% baseballnewssource.com
7/3/2022 Relay Therapeutics (NASDAQ:RLAY) Trading Up 4.7% etfdailynews.com
7/2/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post Q2 2022 Earnings of ($0.58) Per Share, Jefferies Financial Group Forecasts etfdailynews.com
7/2/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post Q2 2022 Earnings of ($0.58) Per Share, Jefferies Financial Group Forecasts defenseworld.net
7/2/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post Q2 2022 Earnings of ($0.58) Per Share, Jefferies Financial Group Forecasts zolmax.com
7/2/2022 Analyzing Ocugen (NASDAQ:OCGN) & Relay Therapeutics (NASDAQ:RLAY) baseballnewssource.com
7/2/2022 Relay Therapeutics (NASDAQ:RLAY) and Ocugen (NASDAQ:OCGN) Head to Head Comparison - American Banking News American Banking News
7/1/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Analysts American Banking News
7/1/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Analysts etfdailynews.com
7/1/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Rating of “Moderate Buy” by Analysts defenseworld.net
7/1/2022 Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells $160,000.00 in Stock zolmax.com
7/1/2022 Relay Therapeutics (NASDAQ:RLAY) Stock Price Up 4.7% - The Cerbat Gem thecerbatgem.com
6/30/2022 Head to Head Analysis: Relay Therapeutics (NASDAQ:RLAY) & Ocugen (NASDAQ:OCGN) etfdailynews.com
6/30/2022 Comparing Relay Therapeutics (NASDAQ:RLAY) & Ocugen (NASDAQ:OCGN) defenseworld.net
6/30/2022 Donald A. Bergstrom Sells 8,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock etfdailynews.com
6/30/2022 Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 1.9% After Insider Selling - Ticker Report Ticker Report
6/30/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Forecasted to Post Q2 2022 Earnings of ($0.58) Per Share theenterpriseleader.com
6/30/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Forecasted to Post Q2 2022 Earnings of ($0.58) Per Share thelincolnianonline.com
6/30/2022 Brokers Set Expectations for Relay Therapeutics, Inc.'s Q2 2022 Earnings (NASDAQ:RLAY) The Markets Daily